Send us Feedback

Advanced Medical Optics (EYE)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
OPERATING METRICS
REVENUE SOURCES
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW

EYE » Topics » SG&A Expense

This excerpt taken from the EYE 8-K filed Oct 31, 2008.

SG&A Expense

 

  •  

Declined 14.4% to $118.1 million; represented 42.8% of sales, compared to $137.9 million or 50.5% of sales in the year-ago period.

 

  •  

Included a $1.8 million charge for accelerated depreciation of the former IntraLase headquarters building associated with the restructuring.

 

  •  

Included $17.1 million in intangible amortization, compared to $16.8 million in the year-ago period.

 

  •  

Year-ago SG&A included approximately $5.1 million in transaction-related charges and approximately $9.3 million in recall-related expenses.

This excerpt taken from the EYE 8-K filed Aug 4, 2008.

SG&A Expense

 

  •  

Declined 12.5% to $131.0 million; represented 40.9% of sales, compared to 57.3% of sales in the year-ago quarter.

 

  •  

Included $17.2 million in intangible amortization, compared to $16.8 million in the year-ago period.

 

  •  

Included $1.8 million charge associated with accelerated depreciation of leasehold improvements related to the restructuring.

 

  •  

Year-ago SG&A included approximately $14.5 million in transaction-related charges and approximately $7.5 million in recall-related expenses.

This excerpt taken from the EYE 8-K filed May 1, 2008.

SG&A Expense

 

  •  

Rose 15.9% to $126.9 million; represented 41.8% of sales vs. 43.5% of sales in the year-ago quarter.

 

  •  

Reflected the addition of IntraLase expenses.

 

  •  

Included $17.1 million in intangible amortization, compared to $9.9 million in the year-ago period.

EXCERPTS ON THIS PAGE:

8-K
Oct 31, 2008
8-K
Aug 4, 2008
8-K
May 1, 2008

RELATED TOPICS for EYE:

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki